MedPath

上海浦津林州制药有限公司

Ownership
-
Established
2005-04-12
Employees
-
Market Cap
-
Website
shpjlz.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

36

NMPA:36

Drug Approvals

Dexamethasone Sodium Phosphate Injection

Product Name
地塞米松磷酸钠注射液
Approval Number
国药准字H41022642
Approval Date
Oct 11, 2023
NMPA

Dexamethasone Sodium Phosphate Injection

Product Name
地塞米松磷酸钠注射液
Approval Number
国药准字H41022643
Approval Date
Oct 11, 2023
NMPA

Sterile Water for Injection

Product Name
灭菌注射用水
Approval Number
国药准字H20227114
Approval Date
Sep 13, 2022
NMPA

Amikacin Sulfate Injection

Product Name
硫酸阿米卡星注射液
Approval Number
国药准字H41022644
Approval Date
Sep 16, 2021
NMPA

Potassium Chloride Injection

Product Name
氯化钾注射液
Approval Number
国药准字H41022236
Approval Date
Mar 30, 2020
NMPA

Vitamin B12 Injection

Product Name
维生素B12注射液
Approval Number
国药准字H41023561
Approval Date
Mar 30, 2020
NMPA

Sodium Bicarbonate Injection

Product Name
碳酸氢钠注射液
Approval Number
国药准字H41022238
Approval Date
Mar 30, 2020
NMPA

Gentamicin Sulfate Injection

Product Name
硫酸庆大霉素注射液
Approval Number
国药准字H41022646
Approval Date
Mar 30, 2020
NMPA

Sterile Water for Injection

Product Name
灭菌注射用水
Approval Number
国药准字H41024231
Approval Date
Mar 30, 2020
NMPA

Lidocaine Hydrochloride Injection(for Solvent)

Product Name
盐酸利多卡因注射液(溶剂用)
Approval Number
国药准字H41024779
Approval Date
Mar 30, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.